To the Editor, Recently, we cared for a 5-month-old baby boy born at 28 weeks gestation with a 1.9-mm patent ductus arteriosus (Fig 1). The parents were counselled regarding the plan for percutaneous device closure and asked to return 2 weeks later. Surprisingly, on repeat echocardiogram, the ductus arteriosus had closed. As spontaneous ductal closure is unusual past the newborn period, we questioned the parents about the events in the preceding 2 weeks. The parents reported administering paracetamol 12 mg/kg/dose twice daily for 4 days because of fussiness and nasal congestion. In premature infants during the newborn period, indomethacin or ibuprofen are first-line agents utilised for ductal closure. In patients with contraindications to non-steroidal anti-inflammatory drugs, paracetamol at 15 mg/kg/dose every 6 hours for 48 hours has been used effectively as a second-line agent. 1,2 Previous authors have suggested that paracetamol works by acting at the peroxidase segment of prostaglandin synthetase and inhibits activity. 3 To the best of our knowledge, our case is the first reported case of ductal closure associated with paracetamol outside of the newborn period. Further studies are needed to elucidate the role of paracetamol for ductal closure beyond the neonatal period.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.